Literature DB >> 15699447

Endurance exercise training in orthostatic intolerance: a randomized, controlled trial.

Robert Winker1, Alfred Barth, Daniela Bidmon, Ivo Ponocny, Michael Weber, Otmar Mayr, David Robertson, André Diedrich, Richard Maier, Alex Pilger, Paul Haber, Hugo W Rüdiger.   

Abstract

Orthostatic intolerance is a syndrome characterized by chronic orthostatic symptoms of light-headedness, fatigue, nausea, orthostatic tachycardia, and aggravated norepinephrine levels while standing. The aim of this study was to assess the protective effect of exercise endurance training on orthostatic symptoms and to examine its usefulness in the treatment of orthostatic intolerance. 2768 military recruits were screened for orthostatic intolerance by questionnaire. Tilt-table testing identified 36 cases of orthostatic intolerance out of the 2768 soldiers. Subsequently, 31 of these subjects with orthostatic intolerance entered a randomized, controlled trial. The patients were allocated randomly to either a "training" (3 months jogging) or a "control" group. The influence of exercise training on orthostatic intolerance was assessed by determination of questionnaire scores and tilt-table testing before and after intervention. After training, only 6 individuals of 16 still had orthostatic intolerance compared with 10 of 11 in the control group. The Fisher exact test showed a highly significant difference in diagnosis between the 2 groups (P=0.008) at the end of the study. Analysis of the questionnaire-score showed significant interaction between time and group (P=0.001). The trained subjects showed an improvement in the average symptom score from 1.79+/-0.4 to 1.04+/-0.4, whereas the control subjects showed no significant change in average symptom score (2.09+/-0.6 and 2.14+/-0.5, respectively). Our data demonstrate that endurance exercise training leads to an improvement of symptoms in the majority of patients with orthostatic intolerance. Therefore, we suggest that endurance training should be considered in the treatment of orthostatic intolerance patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699447     DOI: 10.1161/01.HYP.0000156540.25707.af

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

Review 1.  Postural tachycardia syndrome--current experience and concepts.

Authors:  Christopher J Mathias; David A Low; Valeria Iodice; Andrew P Owens; Mojca Kirbis; Rodney Grahame
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Effects of exercise training on arterial-cardiac baroreflex function in POTS.

Authors:  M Melyn Galbreath; Shigeki Shibata; Tiffany B VanGundy; Kazunobu Okazaki; Qi Fu; Benjamin D Levine
Journal:  Clin Auton Res       Date:  2010-11-20       Impact factor: 4.435

3.  Postural orthostatic tachycardia syndrome (POTS).

Authors:  Bharat Sidhu; Nonyelum Obiechina; Noman Rattu; Shanta Mitra
Journal:  BMJ Case Rep       Date:  2013-09-16

4.  Body Mass Index (BMI) is Associated with the Therapeutic Response to Oral Rehydration Solution in Children with Postural Tachycardia Syndrome.

Authors:  Hongxia Li; Yuli Wang; Ping Liu; Yonghong Chen; Xueli Feng; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  Pediatr Cardiol       Date:  2016-06-27       Impact factor: 1.655

Review 5.  A definition of normovolaemia and consequences for cardiovascular control during orthostatic and environmental stress.

Authors:  Jasper Truijen; Morten Bundgaard-Nielsen; Johannes J van Lieshout
Journal:  Eur J Appl Physiol       Date:  2010-01-07       Impact factor: 3.078

6.  Short-term aerobic exercise reduces nitroglycerin-induced orthostatic intolerance in older adults with type 2 diabetes.

Authors:  Kenneth M Madden; Chris K Lockhart; Tiffany F Potter; Darcye J Cuff; Graydon S Meneilly
Journal:  J Cardiovasc Pharmacol       Date:  2011-06       Impact factor: 3.105

7.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

8.  Twenty-four-hour urine NE level as a predictor of the therapeutic response to metoprolol in children with recurrent vasovagal syncope.

Authors:  Qingyu Kong; Xiaofei Yang; Zhifeng Cai; Yanyan Pan; Minmin Wang; Mengmeng Liu; Cuifen Zhao
Journal:  Ir J Med Sci       Date:  2019-02-13       Impact factor: 1.568

Review 9.  Adolescent fatigue, POTS, and recovery: a guide for clinicians.

Authors:  Sarah J Kizilbash; Shelley P Ahrens; Barbara K Bruce; Gisela Chelimsky; Sherilyn W Driscoll; Cynthia Harbeck-Weber; Robin M Lloyd; Kenneth J Mack; Dawn E Nelson; Nelly Ninis; Paolo T Pianosi; Julian M Stewart; Karen E Weiss; Philip R Fischer
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2014 May-Jun

Review 10.  POTS versus deconditioning: the same or different?

Authors:  Michael J Joyner; Shizue Masuki
Journal:  Clin Auton Res       Date:  2008-08-12       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.